Mutational and Structural Analysis of KIR3DL1 Reveals a Lineage-Defining Allotypic Dimorphism That Impacts Both HLA and Peptide Sensitivity
about
Interaction of a dengue virus NS1-derived peptide with the inhibitory receptor KIR3DL1 on natural killer cellsSuppression of a Natural Killer Cell Response by Simian Immunodeficiency Virus PeptidesThe structure of the atypical killer cell immunoglobulin-like receptor, KIR2DL4.Development of a novel multiplex PCR assay to detect functional subtypes of KIR3DL1 allelesHLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer ImmunotherapyKIR diversity in Māori and Polynesians: populations in which HLA-B is not a significant KIR ligand.The interaction of KIR3DL1*001 with HLA class I molecules is dependent upon molecular microarchitecture within the Bw4 epitopeKey role of human leukocyte antigen in modulating human immunodeficiency virus progression: An overview of the possible applications.Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1.KIR3DS1-Specific D0 Domain Polymorphisms Disrupt KIR3DL1 Surface Expression and HLA Binding.Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition.Deciphering the killer-cell immunoglobulin-like receptor system at super-resolution for natural killer and T-cell biology.A bird's eye view of NK cell receptor interactions with their MHC class I ligands.NK cells: tuned by peptide?KIR3DL1/ HL A-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation.Natural Killer (NK) Cell Education Differentially Influences HIV Antibody-Dependent NK Cell Activation and Antibody-Dependent Cellular Cytotoxicity.Recipient-donor KIR ligand matching prevents CMV reactivation post-haploidentical T cell-replete transplantation.MHC-I peptides get out of the groove and enable a novel mechanism of HIV-1 escape.KIR3DL1 and HLA-B Density and Binding Calibrate NK Education and Response to HIV.KIR and HLA genotypes predictive of low-affinity interactions are associated with lower relapse in autologous hematopoietic cell transplantation for acute myeloid leukemia.Adverse drug reactions triggered by the common HLA-B*57:01 variant: virtual screening of DrugBank using 3D molecular docking.Natural Killer Cell Education and the Response to Infection and Cancer Therapy: Stay Tuned.Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1.Recipient expression of ligands for donor inhibitory KIRs enhances NK-cell function to control leukemic relapse after haploidentical transplantation.Structural Differences in KIR3DL1 and LILRB1 Interaction with HLA-B and the Loading Peptide Polymorphisms:In SilicoEvidences
P2860
Q26314406-A50BDBAA-916D-4260-94D3-BC9B3B8AB0C7Q27317377-6A5DB204-BF9D-4F77-9841-6E91F0AD5446Q30372604-9BE0C416-8F49-4EE8-8462-DDC8BC5925ADQ33740971-DD54495D-98E8-4AA9-B5CE-DFFEDA5CC7C9Q33785744-75EF9219-DCB3-4AC0-A0D7-950D71C24B31Q34345310-EDAD7197-999C-443A-88EF-EE55148053C9Q34810328-B987DA23-0B55-40D1-9119-ADCD2C0883EBQ35567805-3B8F355F-9E11-4804-844F-E7330ED7CB41Q35641485-E5A4A37B-EA40-40E5-9387-2F1C4E203700Q35864564-F85A1D78-FADC-430F-A9E5-9C748225B44AQ36863181-27080F39-3875-485E-8216-8C02BC4401C9Q37622486-96D45B6D-D69B-4C4B-A050-815EAFBDA8BBQ38568874-211104C5-3BA7-461D-BD24-AAD7CE1E6861Q38568884-EA95BD2C-AA99-49BF-ADAD-8CF26DCED932Q38703075-87BA9605-BEB8-4743-92C0-E166FD4BCC0BQ40052007-19A48767-4214-4252-BB2E-616742921A8DQ40217725-16C64CE4-A84E-4FBB-9EA6-C9C6A96C0D86Q40325429-54B71523-5039-4E35-9E8C-9C41161C9BF6Q40760920-0392C7CF-0291-49A6-9B24-E616B6DD7636Q46269995-64D9B36E-1D49-4203-8606-BFC506E4CD7CQ47703247-6B2C30E6-7916-4E8D-88D9-275651A5DE0BQ49351739-640B0376-435E-45B8-A07E-3C30B71854DBQ52692807-6728A3F2-F3DD-4812-B1CB-0DA9EA6A47D3Q53515356-A88AB324-CC11-4527-A1C5-A23A8E2EF820Q59103272-90AFD7AE-FE04-4A1D-963D-A3210BAA2185
P2860
Mutational and Structural Analysis of KIR3DL1 Reveals a Lineage-Defining Allotypic Dimorphism That Impacts Both HLA and Peptide Sensitivity
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Mutational and Structural Anal ...... th HLA and Peptide Sensitivity
@ast
Mutational and Structural Anal ...... th HLA and Peptide Sensitivity
@en
Mutational and Structural Anal ...... th HLA and Peptide Sensitivity
@nl
type
label
Mutational and Structural Anal ...... th HLA and Peptide Sensitivity
@ast
Mutational and Structural Anal ...... th HLA and Peptide Sensitivity
@en
Mutational and Structural Anal ...... th HLA and Peptide Sensitivity
@nl
prefLabel
Mutational and Structural Anal ...... th HLA and Peptide Sensitivity
@ast
Mutational and Structural Anal ...... th HLA and Peptide Sensitivity
@en
Mutational and Structural Anal ...... th HLA and Peptide Sensitivity
@nl
P2093
P2860
P50
P3181
P356
P1476
Mutational and structural anal ...... th HLA and peptide sensitivity
@en
P2093
Daniel W McVicar
Emma Gostick
John S Bridgeman
P2860
P304
P3181
P356
10.4049/JIMMUNOL.1303142
P407
P50
P577
2014-02-21T00:00:00Z